Clinical Trials Logo

Clinical Trial Summary

Several preliminary studies have shown that diet can have beneficial effects on cognitive decline. Among food shown to have such effects are some polyphenols from selected botanicals.

Preclinical studies have concluded that polyphenols play a role in moderation of oxidative stress and inflammation, increased neuronal signaling, and improved metabolic function among other effects. Noteworthy, a positive and statistically significant association between the midlife level of polyphenol intake and cognitive function assessed 13 years later was found in a cohort of 2574 adults.

Several mechanisms may be involved in these positive effects of food polyphenols on cognitive function in older adults: experimental studies suggest that polyphenols display neuroprotective effects, enhancement of the neuronal function, stimulation of brain flow and inducing neurogenesis, and might prevent age-related damage to the central nervous system through their antioxidant and anti-inflammatory activities.

Based on these promising results, a food supplement from botanicals offering complementary polyphenol profile was developed. This food supplement is aimed to aid at maintenance of cognitive function in older adults.


Clinical Trial Description

This project aims to investigate the effects of 6 months supplementation with a polyphenol-rich supplement vs. placebo to consume daily on human cognitive function. Polyphenol-rich supplement and placebo will be provided as capsules matched for appearance.

The study will be conducted as a randomized, double-blind, parallel-groups (2 arms) placebo-controlled, multicentre interventional design. Two groups, each of 102 volunteers, are studied. One group of volunteers will consume the polyphenol-rich product while the other one will consume the placebo product.

Each volunteer will be seen for 3 visits at the investigational site, will have 2 follow-up calls and mid-term dietary survey. Baseline and follow-up visit will include cognitive assessment with the CANTAB battery. CANTAB tests will cover several aspects of memory: visio-spatial learning and episodic memory, verbal recognition memory and visio-spatial working memory. Moreover, psychological and mood components will be evaluated (mnesic complaint, depression, fatigue). Physical activity and food habits will also be recorded. Finally, biological parameters will be assessed (lipid profile, glycemia, insulinemia, CRPus, thyroid stimulating hormone, transthyretin, plasma level of phenolic compounds). ;


Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Prevention


Related Conditions & MeSH terms


NCT number NCT02063646
Study type Interventional
Source Neurophenols Consortium
Contact
Status Completed
Phase N/A
Start date February 2014
Completion date March 2015

See also
  Status Clinical Trial Phase
Recruiting NCT04795284 - Biomechanical Parameters of Gait in Patients With Symptomatic Lumbar Spinal Stenosis and Healthy Elderly.
Completed NCT02235168 - Effect of Rollator on Walking Distance in Elderly Patients N/A
Terminated NCT01421446 - Study to Validate a Computerized Neuropsychological Test Battery N/A
Completed NCT03536871 - Exercise and Nutritional Supplementation N/A
Completed NCT06435078 - Developments of Novel Virtual Visual and Haptic Stimulation Systems for the Elderly N/A
Completed NCT06417034 - Hand Training Device For Cognitive Care N/A
Recruiting NCT03691129 - Yoga Efficacy and Bioactive Materials in the Blood of Korean Elderly N/A
Completed NCT02376270 - Pectin, Aging and Intestinal Barrier Function Phase 4
Terminated NCT02170012 - A Study In Healthy Elderly People To Evaluate Safety, Toleration, Pharmacokinetics and Pharmacodynamics of Multiple Oral Doses Of PF-06743649 Phase 1
Completed NCT04028648 - Generation of Prediction Equations for BIA of the Elderly
Completed NCT02036645 - SAD/MAD Study to Assess Safety, Tolerability, PK & PD of MEDI1814 in Subjects With Mild-Moderate Alzheimer's Disease. Phase 1
Completed NCT04350177 - A Study to Assess Single and Multiple Doses of IkT-148009 in Healthy Elderly Participants and Parkinson's Patients Phase 1
Recruiting NCT05827653 - MAD Study of NX210c Phase 1
Completed NCT00931814 - Effects of Exercise on Depression Symptoms, Physical Function, and Quality of Life in Community-Dwelling Elderly N/A
Withdrawn NCT02765425 - Training the Brain With a Robotic Device for Balance Recovery N/A
Completed NCT02125305 - Clinical Study to Investigate the Pharmacokinetics and Pharmacodynamics of Metformin in the Elderly Phase 1
Completed NCT01188382 - Reference Values of Cerebrospinal Fluid Outflow Resistance and Intracranial Pressure in Healthy Elderly N/A
Suspended NCT04086589 - Restoring Molecular Circadian Rhythm